标题
Antioxidant properties of HDL
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 6, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2015-10-16
DOI
10.3389/fphar.2015.00222
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Apolipoprotein M in lipid metabolism and cardiometabolic diseases
- (2015) Anna Borup et al. CURRENT OPINION IN LIPIDOLOGY
- Catalytic Stimulation by Restrained Active-Site Floppiness—The Case of High Density Lipoprotein-Bound Serum Paraoxonase-1
- (2015) Moshe Ben-David et al. JOURNAL OF MOLECULAR BIOLOGY
- Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease
- (2014) Yoko Haraguchi et al. ATHEROSCLEROSIS
- Human Paraoxonase 1 as a Pharmacologic Agent: Limitations and Perspectives
- (2014) Priyanka Bajaj et al. TheScientificWorldJOURNAL
- Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex
- (2013) Ying Huang et al. JOURNAL OF CLINICAL INVESTIGATION
- Cardioprotective functions of HDLs
- (2013) Kerry-Anne Rye et al. JOURNAL OF LIPID RESEARCH
- Association of paraoxonase gene polymorphisms with diabetic nephropathy and retinopathy
- (2013) JUN WANG et al. Molecular Medicine Reports
- Lipid Oxidation in Carriers of Lecithin:Cholesterol Acyltransferase Gene Mutations
- (2012) Adriaan G. Holleboom et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Lipid complex of apolipoprotein A-I mimetic peptide 4F is a novel platform for paraoxonase-1 binding and enhancing its activity and stability
- (2012) Vinod K. Mishra et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- High-density lipoprotein impedes glycation of low-density lipoprotein
- (2012) Nahla N Younis et al. Diabetes & Vascular Disease Research
- Quantitative Assessment of the Influence of Paraoxonase 1 Activity and Coronary Heart Disease Risk
- (2012) Mingsong Wang et al. DNA AND CELL BIOLOGY
- Phospholipase A2 enzymes and the risk of atherosclerosis
- (2012) R. S. Rosenson et al. EUROPEAN HEART JOURNAL
- Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL
- (2011) Sara Elsøe et al. ATHEROSCLEROSIS
- Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity
- (2011) Mira Rosenblat et al. BIOFACTORS
- Oxidized Low-Density Lipoprotein and Atherosclerosis
- (2010) Daniel Steinberg et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities
- (2010) Anatol Kontush et al. CURRENT OPINION IN LIPIDOLOGY
- Small-dense LDL and LDL glycation in metabolic syndrome and in statin-treated and non-statin-treated type 2 diabetes
- (2010) Nahla N Younis et al. Diabetes & Vascular Disease Research
- Studies on protective effects of human paraoxonases 1 and 3 on atherosclerosis in apolipoprotein E knockout mice
- (2010) C Zhang et al. GENE THERAPY
- Variation in paraoxonase-1 activity and atherosclerosis
- (2009) Handrean Soran et al. CURRENT OPINION IN LIPIDOLOGY
- Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro
- (2008) Nahla Younis et al. ATHEROSCLEROSIS
- Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties
- (2008) Orit Rozenberg et al. FREE RADICAL BIOLOGY AND MEDICINE
- Relationship of Paraoxonase 1 (PON1) Gene Polymorphisms and Functional Activity With Systemic Oxidative Stress and Cardiovascular Risk
- (2008) Tamali Bhattacharyya JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started